Phillip P. Chan, Chief Executive Officer at Cytosorbents Corp (CTSO), bought 5,859 shares at $1.26 ($7K) on 2022-12-08, disclosed to the SEC on 2022-12-09.
Open-market purchase of $7k CTSO by Chief Executive Officer. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Nothing distinguishes this filing.
| Filing → |
| CTSO | BUY | 2026-06-15 | $105K | — | Filing → |
| CTSO | BUY | 2023-12-15 | $200K | — | Filing → |
| CTSO | BUY | 2022-12-08 | $30K | — | Filing → |